Physician profile
Nancy Tray
NPI 1306112677
$855.42
in general payments reported to CMS, 2019-2025
19 companies · $98.22 in 2025
The $98.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2021: $121 · 2022: $174 · 2023: $118 · 2024: $17.02 · 2025: $98.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148 · Education: $85.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.19 |
| Education | $85.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $218.56 | 2019-2023 | Opdivo |
| Janssen Biotech, INC. | $162.26 | 2019-2023 | Rybrevant |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Incyte Corporation | $50.62 | 2022 | |
| Tesaro, INC. | $44.27 | 2019 | |
| Daiichi Sankyo INC. | $36.38 | 2021 | |
| Novocure INC. | $29.73 | 2025 | Optune Gio |
| Lilly USA, LLC | $25.50 | 2021 | |
| Abbvie INC. | $25.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.56 | 2022 | |
| G1 Therapeutics, INC. | $23.53 | 2022 | |
| Emd Serono, INC. | $22.41 | 2022 | |
| Rigel Pharmaceuticals, INC. | $21.76 | 2022 | |
| Glaxosmithkline, LLC. | $19.85 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.02 | 2024 | Libtayo |
| Verastem, INC. | $14.92 | 2019 | |
| Genentech USA, INC. | $14.04 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Tray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.